Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
LongGame is a venture capital organization based in the United States, dedicated to funding technologies that significantly extend healthy human lifespan. The firm focuses on radical lifespan extension through investments in longevity biotech companies. Specific details about fund size and team composition are not disclosed.
LongGame invests exclusively in technologies that aim to extend human life beyond current limits, specifically targeting a minimum increase of 10 years in healthy lifespan. The firm emphasizes scalable solutions that benefit global populations, not just the wealthy. Key areas of interest include AI, synthetic biology, stem cell therapies, gene sequencing and editing, protein engineering, and tissue engineering.
LongGame invests in technologies designed to extend human life, focusing on solutions that can increase healthy lifespan by at least 10 years. The firm prioritizes scalable innovations that can benefit a broad population.
The firm primarily targets the longevity biotech sector, investing in advancements across various fields such as AI, synthetic biology, and gene editing.
While specific stage preferences are not detailed, LongGame's focus on radical innovations suggests a willingness to engage with early-stage companies that align with their longevity goals.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.